Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G MORGAN

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
European Journal of Pharmacology|September 1, 1994
The presence of islet amyloid polypeptide/calcitonin gene-related peptide/salmon calcitonin binding sites in the rat nucleus accumbensP R Veale, R Bhogal, D G Morgan, et al.
Lancet (London, England)|December 1, 1979
Site of Epstein-Barr virus replication in the oropharynxD G Morgan, J C Niederman, G Miller, et al.
Journal of Chromatography. A|June 8, 2000
Case of enantiomer impurity identification by normal-phase chiral high-performance liquid chromatography with optical rotation and mass spectrometric detectionC A Goss, D G Morgan, K L Harbol, et al.
Synapse (New York, N.Y.)|December 1, 1991
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theoriesS Caldecott-Hazard, D G Morgan, F DeLeon-Jones, et al.
European Journal of Pharmacology|December 15, 1984
Hyperprolactinemia fails to increase striatal dopamine receptors in male and female C57BL/6J miceD G Morgan, C V Mobbs, C P Anderson, et al.
Journal of Neuroendocrinology|April 1, 1996
Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinityD G Morgan, P D Lambert, D M Smith, et al.
Journal of Neurochemistry|November 1, 1990
Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpineG M Pasinetti, D G Morgan, S A Johnson, et al.
Pharmaceutical Research|January 6, 2001
A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicologyP J Bugelski, U Atif, S Molton, et al.
Thrombosis Research|February 1, 1989
Uptake of human recombinant tissue-type plasminogen activator by rat hepatocytes in vivo: an electron microscope autoradiographic studyP J Bugelski, K L Fong, A Klinkner, et al.
The British Journal of Surgery|February 1, 1993
Limitations of laser treatment for malignant dysphagiaD G Morgan, C J de Gara, V Basrur, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
European Journal of Pharmacology|September 1, 1994
The presence of islet amyloid polypeptide/calcitonin gene-related peptide/salmon calcitonin binding sites in the rat nucleus accumbensP R Veale, R Bhogal, D G Morgan, et al.
Lancet (London, England)|December 1, 1979
Site of Epstein-Barr virus replication in the oropharynxD G Morgan, J C Niederman, G Miller, et al.
Journal of Chromatography. A|June 8, 2000
Case of enantiomer impurity identification by normal-phase chiral high-performance liquid chromatography with optical rotation and mass spectrometric detectionC A Goss, D G Morgan, K L Harbol, et al.
Synapse (New York, N.Y.)|December 1, 1991
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theoriesS Caldecott-Hazard, D G Morgan, F DeLeon-Jones, et al.
European Journal of Pharmacology|December 15, 1984
Hyperprolactinemia fails to increase striatal dopamine receptors in male and female C57BL/6J miceD G Morgan, C V Mobbs, C P Anderson, et al.
Journal of Neuroendocrinology|April 1, 1996
Reduced NPY induced feeding in diabetic but not steroid-treated rats: lack of evidence for changes in receptor number or affinityD G Morgan, P D Lambert, D M Smith, et al.
Journal of Neurochemistry|November 1, 1990
Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpineG M Pasinetti, D G Morgan, S A Johnson, et al.
Pharmaceutical Research|January 6, 2001
A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicologyP J Bugelski, U Atif, S Molton, et al.
Thrombosis Research|February 1, 1989
Uptake of human recombinant tissue-type plasminogen activator by rat hepatocytes in vivo: an electron microscope autoradiographic studyP J Bugelski, K L Fong, A Klinkner, et al.
The British Journal of Surgery|February 1, 1993
Limitations of laser treatment for malignant dysphagiaD G Morgan, C J de Gara, V Basrur, et al.
Pageof 16